Mesa Laboratories (NASDAQ:MLAB) Earns News Impact Score of 0.08

News articles about Mesa Laboratories (NASDAQ:MLAB) have trended somewhat positive on Friday, Accern Sentiment Analysis reports. The research group ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Mesa Laboratories earned a media sentiment score of 0.08 on Accern’s scale. Accern also assigned news articles about the medical instruments supplier an impact score of 46.1191998137545 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Mesa Laboratories (NASDAQ MLAB) traded up $1.01 during trading on Friday, hitting $132.93. 3,500 shares of the stock traded hands, compared to its average volume of 13,458. The firm has a market cap of $498.62, a price-to-earnings ratio of 47.99 and a beta of 0.42. Mesa Laboratories has a one year low of $113.57 and a one year high of $169.80. The company has a quick ratio of 1.97, a current ratio of 2.86 and a debt-to-equity ratio of 0.48.

Mesa Laboratories (NASDAQ:MLAB) last announced its quarterly earnings results on Monday, November 6th. The medical instruments supplier reported $0.60 EPS for the quarter, missing the Zacks’ consensus estimate of $0.64 by ($0.04). Mesa Laboratories had a net margin of 11.48% and a return on equity of 14.77%. The company had revenue of $22.95 million during the quarter, compared to analyst estimates of $25.50 million. sell-side analysts anticipate that Mesa Laboratories will post 2.47 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 15th. Stockholders of record on Wednesday, February 28th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.48%. The ex-dividend date of this dividend is Tuesday, February 27th. Mesa Laboratories’s dividend payout ratio (DPR) is presently 23.10%.

Several research firms recently commented on MLAB. TheStreet raised shares of Mesa Laboratories from a “c+” rating to a “b” rating in a research report on Monday, November 6th. Zacks Investment Research upgraded shares of Mesa Laboratories from a “strong sell” rating to a “buy” rating and set a $167.00 price target on the stock in a research note on Tuesday, October 3rd.

COPYRIGHT VIOLATION NOTICE: “Mesa Laboratories (NASDAQ:MLAB) Earns News Impact Score of 0.08” was first published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright & trademark law. The original version of this piece of content can be read at https://stocknewstimes.com/2018/01/19/mesa-laboratories-mlab-receives-daily-coverage-optimism-rating-of-0-08.html.

About Mesa Laboratories

Mesa Laboratories, Inc is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products.

Insider Buying and Selling by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply